A perspective on US drug reimportation

JAMA

Volumn 293, Issue 3, 2005, Pages 358-362

  Choudhry, Niteesh K ^a,d   Detsky, Allan S ^b,c  

^a HARVARD MEDICAL SCHOOL   (United States)

^b UNIVERSITY OF TORONTO   (Canada)

^c UNIVERSITY HEALTH NETWORK   (Canada)

^d BRIGHAM AND WOMEN S HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CANADA; DRUG COST; DRUG INDUSTRY; DRUG MARKETING; DRUG SAFETY; FOOD AND DRUG ADMINISTRATION; HEALTH SURVEY; NOTE; POLICY; PRESCRIPTION; PRIORITY JOURNAL; PROFIT; UNITED STATES;

EID: 12244252780     PISSN: 00987484     EISSN: None     Source Type: Journal    
DOI: 10.1001/jama.293.3.358     Document Type: Note

References (59)

1. Lester W. The Associated Press/Ipsos Poll. Almost a third of Americans say paying for drugs is a problem in their families. Available at: http://www.ipsos-na.com/news/pressrelease.cfm?id=2064#. Accessed April 23, 2004.
2. Rector TS, Venus PJ. Do drug benefits help Medicare beneficiaries afford prescribed drugs? Health Aff (Millwood). 2004;23:213-222.
3. Lueck S, Mathews AW. Drug makers not out of woods; legalizing Canadian imports has support on both sides of aisle. Wall Street Journal. April 13, 2004:A4.
4. Wagner JL, McCarthy E. International differences in drug prices. Annu Rev Public Health. 2004;25:475-495.
5. The Wall Street Journal Online/Harris Interactive Health Care Poll. Drug companies may be headed for a bruising battle as drug importation grows. Available at: http://www.harrisinteractive.com/news/newsletters/wsjhealthnews/ WSJOnline_HI_Health-CarePoll2003vol2_iss8.pdf. Accessed April 23, 2004.
6. AARP July 2004 Rx importation survey. Available at: http://www.aarp.org/ research/press/presscurrentnews/Articles/a2004-07-16-survey.html. Accessed August 27, 2004.
7. Nitkin D, Zaneski CT. Senate pursues drugs plan. Baltimore Sun, March 31, 2004:1B.
8. Wilson JF. Cheaper drugs in foreign markets increase the focus on domestic drug prices. Ann Intern Med. 2004;140:677-680.
9. Marimow AE. Assembly approves bill for Canadian medicines. Contra Costa Times. August 26, 2004:A09.
10. Wolfe W. State's mail-order drug plan launched. Minneapolis Star Tribune. May 14, 2004:18.
11. Kamath R, McKibbin S. Report on Feasibility of Employees and Retirees Safely and Effectively Purchasing Prescription Drugs From Canadian Pharmacies. Springfield: Illinois Department of Central Management Services; October 27, 2003.
12. Hubbard WK. Statement before the Committee on Government Reform, Subcommittee on Human Rights and Wellness, US House of Representatives. Canadian prescription drug re-importation: is there a safety issue? Available at: http://www.fda.gov/ola/2003/canadian0612.html. Posted June 13, 2003. Accessed April 26, 2004.
13. Saatsoglou P. Pharmaceutical reimportation: magnitude, trends, and consumers. Manag Care. 2004;13:7-9.
14. Connolly C. A small win for proponents of drug importation. Washington Post. April 23, 2004:E01.
15. Connolly C. Pfizer cuts supplies to Canadian drugstores; sales are halted to reimporters of bargain drugs. Washington Post. February 19, 2004:A10.
16. Strahinich J. Novartis: we may cut cheap Canadian drugs. Boston Herald. November 18, 2004:46.
17. Richer S. America's new war on drugs targets Canadian pharmacists. Globe and Mail. May 17, 2004:A1.
18. Majeski T. Prescription drug imports: seniors sue drug makers. St. Paul Pioneer Press. May 20, 2004:B8.
19. Groups ask Canada to ban web pharmacies. Associated Press news release. March 30, 2004.
20. Alexander D. U.S. demands for our medicines worries druggists. Vancouver Sun. August 25, 2004:A1.
21. Sanders B. International prescription drug parity: are Americans being protected or gouged [press release]? Available at: http://bernie.house.gov/ documents/releases/20030402191306.asp. Posted April 2, 2003. Accessed June 7, 2004.
22. Ward C. Economic and policy implications of reimportation: a Canadian perspective. Manag Care. 2004;13:17-20.
23. Health Canada and US Food and Drug Administration sign Memorandum of Understanding for closer collaboration. Available at: http://www.hc-sc.gc.ca/ english/media/releases/2003/2003_86.htm. Posted November 18, 2003. Accessed April 27, 2004.
24. Revised Statutes of Canada. Food and Drugs Act. Part II, section 37.1985;c:F-27. Available at: http://www.hc-sc.gc.ca/food-aliment/friia-raaii/ food_drugs-aliments_drogues/act-loi/pdf/e_a-contnt.pdf. Accessibility verified December 20, 2004.
25. North American Free Trade Agreement. 1994. Available at: http://www.fas.usda.gov/info/factsheets/nafta.html. Accessibility verified December 20, 2004.
26. Pharmaceutical Market Access and Drug Safety Act of 2004. S.2328; Introduced to US Senate in 2004.
27. US Food and Drug Administration. FDA/U.S. Customs import blitz exams reveal hundreds of potentially dangerous imported drug shipments. Available at: http://www.fda.gov/bbs/topics/NEWS/2003/NEW00948.html. Accessed April 28, 2004.
28. US General Accounting Office. Internet pharmacies: some pose safety risks for consumers and are unreliable in their business practices. Available at: http://www.gao.gov/highlights/d04888thigh.pdf. June 17, 2004. Accessed August 27, 2004.
29. Health Canada Health Products and Food Branch. Summary report of the compliance inspections of Canadian pharmacy sites involved in the sale of prescription drugs via the Internet or via distance dispensing. Available at: http://www.hc-sc.gc.ca/hpfb-dgpsa/inspectorate/sale_presc_drug_internet_e.pdf. Accessed November 11, 2004.
30. Gibbons M. An overview from the National Association of Boards of Pharmacy. Manag Care. 2004;13:21-24.
31. Bartlett DL, Steele JB. Has your life become a game of chance? Time. February 2, 2004:51.
32. Scherer FM. The pharmaceutical industry: prices and progress. N Engl J Med. 2004;351:927-932.
33. Danzon PM. The economics of parallel trade. Pharmacoeconomics, 1998;13:293-304.
34. Scherer FM. The link between gross profitability and pharmaceutical R&D spending. Health Aff (Millwood). 2001;20:216-220.
35. Public Citizen's Congress Watch. America's other drug problem: a briefing book on the Rx drug debate. Available at: http://www.citizen.org/documents/ drugbriefingbk.pdf. 2002. Accessed September 8, 2004.
36. Sager A, Socolar D. A prescription drug peace treaty: cutting prices to make prescription drugs affordable for all and to protect research. Available at: http://dcc2.bumc.bu.edu/hs/sager/Peace%20Treaty%2028%20Sept%2000.pdf. Posted September 28, 2000. Accessed December 20, 2004.
37. DiMasi JA, Hansen RW, Grabowski HG. The price of innovation: new estimates of drug development costs. J Health Econ. 2003;22:151-185.
38. US Congress Office of Technology Assessment. Pharmaceutical R&D: Costs, Risks and Rewards. OTA-H-522. Available at: http://www.wws.princeton.edu/ cgi-bin/byteserv.prl/~ota/disk1/1993/9336/9336.PDF. February 1993. Accessed September 1, 2004.
39. Frank RG. New estimates of drug development costs. J Health Econ. 2003;22:325-330.
40. NIH Contributions to Pharmaceutical Development. Bethesda, Md: NIH; 2000.
41. United States General Accounting Office. NIH-private sector partnership in the development of Taxol. Available at: http://www.gao.gov/new.items/d03829. pdf. June 2003. Accessed November 11, 2004.
42. Frank RG. Prescription drug prices: why do some pay more than others do? Health Aff (Millwood). 2001;20:115-128.
43. Sager A, Socolar D. Do drug makers lose money on Canadian imports? Available at http://dcc2.bumc.bu.edu/hs/Canadian_importing_break- even_14_Apr%2004_FINAL.pdf. Posted April 15, 2004. Accessed April 27, 2004.
44. US Department of Health and Human Services. Prescription drug coverage, spending, utilization, and prices. Available at: http://www.aspe.hhs.gov/health/ reports/drugstudy/c3.pdf. Accessed September 8, 2004.
45. Cohen JL, Cassels A. Canada, get ready to defend affordable drugs: as more Americans buy drugs on-line, our prices will be pressured to mirror theirs. Globe and Mail. August 26, 2003:A17.
46. Pear R. Group of senators agrees on drug imports. New York Times. April 22, 2004:A23.
47. Reliable Entry for Medicines at Everyday Discounts through Importation with Effective Safeguards Act of 2004. S.2307; Introduced to US Senate in April 2004.
48. Frank RG. Prescription-drug prices. N Engl J Med. 2004;351:1375-1377.
49. Baker C. Would prescription drug importation reduce U.S. drug spending? Washington, DC: Congressional Budget Office; April 29, 2004. Available at: http://www.cbo.gov/showdoc.cfm?index=5406&sequence=0. Accessibility verified December 20, 2004.
50. Friesen J, LaFlamme L. Dosanjh threatens to cut off Web drugs. Globe and Mail. November 11, 2004.
51. Newhouse JP. How much should Medicare pay for drugs? Health Aff (Millwood). 2004;23:89-102.
52. Frank RG. Government commitment and regulation of prescription drugs. Health Aff (Millwood). 2003;22:46-48.
53. Menon D. Pharmaceutical cost control in Canada: does it work? Health Aff (Millwood). 2001;20:92-103.
54. Maynard A, Bloor K. Dilemmas in regulation of the market for pharmaceuticals. Health Aff (Millwood). 2003;22:31-41.
55. Kanavos P, Reinhardt U. Reference pricing for drugs: is it compatible with U.S. health care? Health Aff (Millwood). 2003;22:16-30.
56. Schneeweiss S, Walker AM, Glynn RJ, Maclure M, Dormuth C, Soumerai SB. Outcomes of reference pricing for angiotensin-converting-enzyme inhibitors. N Engl J Med. 2002;346:822-829.
57. Huskamp HA, Deverka PA, Epstein AM, Epstein RS, McGuigan KA, Frank RG. The effect of incentive-based formularies on prescription-drug utilization and spending. N Engl J Med. 2003;349:2224-2232.
58. Soumerai SB. Benefits and risks of increasing restrictions on access to costly drugs in Medicaid. Health Aff (Millwood). 2004;23:135-146.
59. Huskamp HA, Epstein AM, Blumenthal D. The impact of a national prescription drug formulary on prices, market share, and spending: lessons for Medicare? Health Aff (Millwood). 2003;22:149-158.